S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ACAD Acadia Pharmaceuticals Inc

19.13

0.00 (0.00%)

Pre Market

Last Updated: 00:38:38

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Acadia Pharmaceuticals Charts.

Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Acadia Pharmaceuticals Charts.

Acadia Pharmaceuticals Inc News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 7 February 2025 (3 hours ago) • Edgar (US Regulatory)

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Saturday 18 January 2025 (3 weeks ago) • Business Wire

Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Wednesday 15 January 2025 (3 weeks ago) • Business Wire

Acadia Pharmaceuticals Set to Join S&P SmallCap 600
Tuesday 31 December 2024 (1 month ago) • PR Newswire (US)

Acadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025
Friday 20 December 2024 (2 months ago) • Business Wire

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Tuesday 17 December 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Thursday 12 December 2024 (2 months ago) • Edgar (US Regulatory)

Acadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
Thursday 12 December 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 11 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 11 December 2024 (2 months ago) • Edgar (US Regulatory)

Acadia Pharmaceuticals Appoints Thomas Garner Chief Commercial Officer
Tuesday 10 December 2024 (2 months ago) • Business Wire

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711
Wednesday 27 November 2024 (2 months ago) • Business Wire

More Acadia Pharmaceuticals Inc News Articles

Australia And New Zealan...

Verizon Communications

Newcrest Mining

Commonwealth Bank Of Aus...

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions